1997
DOI: 10.1007/s004310050694
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of interferons in treating children with chronic hepatitis C

Abstract: The genotype of HCV (III) and a reduction in the core antibody titre appear to be useful parameters for predicting the response to IFN-alpha therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
12
0
1

Year Published

1999
1999
2009
2009

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(16 citation statements)
references
References 20 publications
3
12
0
1
Order By: Relevance
“…Recent publications have suggested that children infected after vertical infection have a higher spontaneous clearance than adults. [8][9][10] These results are similar to the horizontal infection of young children after HCV positive blood transfusion. The spontaneous clearance rate in these patients was between 28 and 55%.…”
Section: Discussionsupporting
confidence: 91%
“…Recent publications have suggested that children infected after vertical infection have a higher spontaneous clearance than adults. [8][9][10] These results are similar to the horizontal infection of young children after HCV positive blood transfusion. The spontaneous clearance rate in these patients was between 28 and 55%.…”
Section: Discussionsupporting
confidence: 91%
“…T reatment with alfa-interferon yielded very inconstant results ranging between 5% and 45% sustained response in children with chronic hepatitis C. [1][2][3][4] As in adults, genotype 1, which represents the most frequent genotype in Europe, has a low response rate by an average of 27% as reported by Jacobson et al, 5 who analyzed all relevant published trials in children. This led to the recommendation by some pediatric hepatologists not to treat chronically infected children without progressive disease.…”
mentioning
confidence: 99%
“…Besides, relatively mild liver damage, as evidenced by the histology of the biopsy specimens, may result in a fairly good response to IFN-a treatment in spite of the HCV 1b genotype. The competent immune system of paediatric patients may also contribute to the final result [21]. A sustained ALT response was seen in 50% of cases in our group of patients , while in adults the corresponding percentage is 8-9% [23].…”
Section: Discussionmentioning
confidence: 94%